[Genetic study on schizophrenia and its recurrence utilizing pharmacological models]

[Article in Japanese]

Review

[Article in Japanese]

Toru Nishikawa. Seishin Shinkeigaku Zasshi.2002.

No abstract available

Similar articles

Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
Enomoto T, Noda Y, Nabeshima T.Enomoto T, et al.Methods Find Exp Clin Pharmacol. 2007 May;29(4):291-301. doi: 10.1358/mf.2007.29.4.1075358.Methods Find Exp Clin Pharmacol. 2007.PMID:17609743Review.
Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C.Bubeníková-Valesová V, et al.Neurosci Biobehav Rev. 2008 Jul;32(5):1014-23. doi: 10.1016/j.neubiorev.2008.03.012. Epub 2008 Apr 8.Neurosci Biobehav Rev. 2008.PMID:18471877Review.
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC.Javitt DC.Int Rev Neurobiol. 2007;78:69-108. doi: 10.1016/S0074-7742(06)78003-5.Int Rev Neurobiol. 2007.PMID:17349858Review.
[Development of animal models for schizophrenia based on clinical evidence: expectation for psychiatrists].
Noda Y, Mouri A, Waki Y, Nabeshima T.Noda Y, et al.Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Apr;29(2):47-53.Nihon Shinkei Seishin Yakurigaku Zasshi. 2009.PMID:19562941Review.Japanese.
Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
Mouri A, Noda Y, Enomoto T, Nabeshima T.Mouri A, et al.Neurochem Int. 2007 Jul-Sep;51(2-4):173-84. doi: 10.1016/j.neuint.2007.06.019. Epub 2007 Jun 27.Neurochem Int. 2007.PMID:17669558Review.